Abstract Glutamine, the most abundant amino acid in mammals, is critical for cell and organ functions. Its metabolism depends on the ability of cells to take up or release glutamine by transporters located in the plasma membrane. Several solute carrier (SLC) families transport glutamine, but the SLC38 family has been thought to be mostly responsible for glutamine transport. We demonstrate that despite the large number of glutamine transporters, the loss of Snat3/Slc38a3 glutamine transporter has a major impact on the function of organs expressing it. Snat3 mutant mice were generated by N-ethyl-Nnitrosurea (ENU) mutagenesis and showed stunted growth, altered amino acid levels, hypoglycemia, and died around 20 days after birth. Hepatic concentrations of glutamine, glutamate, leucine, phenylalanine, and tryptophan were highly reduced paralleled by downregulation of the mTOR pathway possibly linking reduced amino acid availability to impaired growth and glucose homeostasis. Snat3-deficient mice had altered urea levels paralleled by dysregulation of the urea cycle, gluconeogenesis, and glutamine synthesis. Mice were ataxic with higher glutamine but reduced glutamate and gamma-aminobutyric acid (GABA) levels in brain consistent with a major role of Snat3 in the glutamine-glutamate cycle. Renal ammonium excretion was lower, and the expression of enzymes and amino acid transporters involved in ammoniagenesis were altered. Thus, SNAT3 is a glutamine transporter required for amino acid homeostasis and determines critical functions in various organs. Despite the large number of glutamine transporters, loss of Snat3 cannot be compensated, suggesting that this transporter is a major route of glutamine transport in the liver, brain, and kidney.
Introduction
Glutamine is the most abundant amino acid in the human body and is involved in more physiological processes than any other amino acid [16, 17, 53] . Glutamine serves as a precursor of purines, pyrimidines, glycogen, glucose, and in protein synthesis [47] and is involved in a myriad of other metabolic processes. It is also a major regulator of key physiologic processes such as hepatic and renal gluconeogenesis, the glutamate/gamma-aminobutyric acid (GABA)-glutamine cycle in the central nervous system (CNS) [36] , hepatic ammonia detoxification [25] , and in renal response to acidosis [52] . Furthermore, glutamine is the major oxidative fuel for rapidly replicating cells such as enterocytes and cells of the immune Electronic supplementary material The online version of this article (doi:10.1007/s00424-015-1742-0) contains supplementary material, which is available to authorized users. system, providing ATP for intracellular protein turnover, nutrient transport through the plasma membrane, cell growth and migration as well as the maintenance of cell integrity [33, 53] . Finally, glutamine is also a key intermediate in interorgan nitrogen and carbon transport [41, 51] . The transport of glutamine across cell membranes is mediated by several amino acid carriers with different specificity for glutamine and other neutral amino acids. To date, at least 4 distinct SLC transporter families have been implicated in glutamine transport, the SLC1 family of glutamate and glutamine transporters, the SLC3-SLC7 heterodimeric family, the SLC6 family of neurotransmitter and neutral amino acid transporters, and the SLC38 family of glutamine transporters [7, 29] . The SLC38 family has at least two major subgroups, the system A transporter of Na + -coupled transporters including SNAT1 (SLC38A1), SNAT2 (SLC38A2), and SNAT4 (SLC38A4) and the system N transporter family of Na + -and H + -coupled transporters SNAT3 (SLC38A3), SNAT5 (SLC38A5), and SNAT7 (SLC38A7) [8] . Whereas system A transporters have a wider substrate spectrum including glutamine, alanine, asparagine, cysteine, serine, methionine, proline, glycine, and histidine, the specificity of system N transporters is narrow transporting only glutamine, histidine, asparagine, and serine [7] . These system N amino acid transporters mediate the uptake of one glutamine molecule with the net uptake of one Na + in exchange of a proton. The other members of the SLC38 family, the system A transporters (SNAT1, SNAT2, SNAT4) are not able for counter-transport of protons [2, 8, 12, 14] . SNAT3 is highly abundant in the liver, kidney, and brain, and its expression has also been reported for adipose tissue, pancreas, skeletal muscle, and the eye. In the kidney, SNAT3 is mainly localized to the proximal tubule, in the liver to both perivenous and periportal hepatocytes, and in the brain mostly in astrocytes and endothelial cells of the blood-brain barrier [13, 22, 37, 43, 46] . In the brain, SNAT3 and SNAT5 have been hypothesized to be responsible for the efflux of glutamine from astrocytes, which is a crucial step in the recycling of glutamate and GABA neurotransmitters between astrocytes and neurons [5, 36] . In the liver, SNAT3 is likely to be a candidate for both periportal uptake and perivenous efflux of glutamine, which is essential for the detoxification of ammonia delivered via the portal blood and excreted as urea [22, 25] . Furthermore, SNAT3 mRNA and protein expression in the kidney is increased in response to metabolic acidosis, possibly providing glutamine for ammoniagenesis in the proximal tubule cell [9, 37, 40, 46] . Plasma glutamine levels decrease substantially during metabolic acidosis [50] , and glutamine flow is redirected from the splanchnic bed to the kidney with SNAT3 proposed to deliver glutamine for renal ammoniagenesis.
To date, all studies addressing the function and regulation of SLC38 amino acid transporters have used either heterologous expression systems or cell culture models. The biological relevance of these transporters, however, has not been examined in any in vivo model to the best of our knowledge. Here we demonstrate that SNAT3 plays a critical role in glutamine transport and metabolism by characterizing a mouse model deficient of Slc38a3.
Materials and methods

Animals
Snat3 mutant mice (Q263X, Hybrid C3H-C57BL/6J) were generated by Ingenium Pharmaceuticals AG (Martinsried, Germany) using N-ethyl-N-nitrosurea (ENU) mutagenesis. The mutation causes a premature stop codon at amino acid position 263 deleting the second half of the protein (Fig. 1b) The animals were maintained at 22±2°C and a 12:12 h light/ dark cycle with access to tap water and standard rodent diet ad libitum (Provimi KLIBA, Kaiseragust, Switzerland). Mice were backcrossed to C57BL6/J and animals from the sixth to tenth generation were used for this study. For all experiments, littermates were used from heterozygous breeding. Analysis of the offspring from heterozygous mating suggested that the ratio of genotypes obtained followed almost a Mendelian inheritance (wildtype (WT) 15 %, Snat3 +/− 56 %, Snat3 −/− 29 %; n=52 pups analyzed). All animal procedures were carried out according to the Swiss Animal Welfare laws and approved by the local veterinary authority (Kantonales Veterinäramt Zurich).
mRNA analysis by semi-quantitative real-time PCR Snap-frozen tissue was homogenized in 1 mL RLT buffer (Qiagen, the Netherlands) supplemented with 2-using RNeasy Mini Kit (Qiagen, the Netherlands) following the manufacturer's instructions. Quality, purity, and concentration of the isolated RNA were assessed using the ND-1000 spectrophotometer (NanoDrop Technologies, USA). Each RNA sample was diluted to 100 ng/μL, and 3 μL was used as a template for reverse transcription using the TaqMan Reverse Transcription Kit (Applied Biosystems, USA). Reverse transcription was performed with the Biometra TGradient thermocycler with thermocycling conditions set at 25°C for 10 min, 48°C for 30 min, and 95°C for 5 min. Semi-quantitative real-time (RT-qPCR) was performed on the ABI PRISM 7700 Sequence Detection System (Applied Biosystems, USA). Thermocycling conditions were as follows: 50°C for 2 min, 95°C for 10 min, and 95°C for 15 s (40 cycles). Primers and probes for all genes were designed using Primer 3 Software developed at Whitehead Institute and Howard Hughes Medical Institute and synthesized at Microsynth (Balgach, Switzerland). Probes were labeled with the reporter dye FAM at the 5′ end and the quencher dye TAMRA at the 3′ end (Microsynth, Balgach, Switzerland). Reactions were run in triplicate, including a negative control (without Multiscribe reverse transcription enzyme). The gene expression was calculated in relation to hypoxanthine guanine phosphoribosyl transferase (HPRT). Relative expression were calculated as 2
. The primers and probes are listed in Supplementary Table 1 .
Antibodies
The primary antibodies used were mouse monoclonal anti-ß-actin (42 kDa; Sigma-Aldrich, Saint Louis, MO, USA; diluted [43] ; diluted 1:1000), and rabbit polyclonal anti-SNAT3 (55 kDa; kindly provided by F. Verrey, University of Zurich, Zurich, ZH, Switzerland [37] ; diluted 1:500). Secondary antibodies used were horseradish peroxidase-conjugated donkey anti-rabbit or anti-mouse (GE Healthcare, Little Chalfont, Buckinghamshire, UK; diluted 1:10,000) and goat alkaline phosphataseconjugated anti-rabbit (Promega, Madison, WI, USA, diluted 1:5000), Alexa 593 anti-rabbit antibody (Invitrogen, Carlsbad, CA, USA; diluted 1:1000), and Alexa 488 donkey anti-goat antibody (Invitrogen Carlsbad, CA, USA; diluted 1:3000).
Protein extraction and immunoblotting
The kidneys, liver, and brain were removed from 14-dayold mice and rapidly frozen in liquid nitrogen. Total membrane and cytosolic proteins were prepared using a K-HEPES buffer (200 mM mannitol, 80 mM K-HEPES, 41 mM KOH, pH 7.5) containing protease inhibitors (PMSF, K-EDTA, and leupeptin). The different organs were homogenized using a Rotor-stator homogenizer. The kidney and liver homogenates were subsequently centrifuged for 20 min at 2000 rpm at 4°C, whereas the brain was centrifuged for 30 min at 3500 rpm at 4°C due to the high content of fat. The supernatant was ultra-centrifuged (Sorvall, Thermo Fisher Scientific, Waltham, MA, USA) for 1 h at 41,000 rpm at 4°C. The resulting supernatant containing the cytosolic proteins was removed and the pellet resuspended in K-HEPES buffer and sonicated briefly to homogenize the proteins solution. Total protein concentration was measured using the Bio-Rad DC protein assay (Bio-Rad, Hercules, CA, USA). Fifty micrograms of crude membrane proteins were solubilized in 2x Laemmli sample buffer, and SDS page was performed on either 6 or 10 % polyacrylamide gels. Proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Immobilon-P, Milipore, Billerica, MA USA). After blocking with 5 % milk powder in Trisbuffered saline/01 % Tween-20 for 1 h, the blots were incubated with primary antibodies either at room temperature for 2 h or overnight at 4°C. The membranes were then washed three times, blocked for 1 h in 5 % milk TBS Tween, and incubated for 1 h at room temperature with secondary antibodies. Membranes were treated with alkaline phosphatase or horseradish peroxidase-conjugated developing solution and exposed to the las4000 chemiluminescence detection system (Fujifilm, Tokyo, Japan). Specific bands on PVDF membranes were quantified using AIDA image analyzer. Eventually, the membranes were stripped and reprobed with other antibodies.
Immunochemistry
The anesthetized mice were perfused with phosphatebuffered saline (PBS, pH 7.4) through the left cardiac ventricle, followed by a 1 % paraformaldehyde/2.5 glutaraldehyde fixative solution. The kidneys, liver, and brain were then harvested and left in the fixative solution overnight. The organs were embedded in OCT compound (Tissue-Tek, Sakura Finetek, Alphen aan den Rijn, the Netherlands) and store at −80°C. For staining, 3-μm-thick tissue sections were prepared using a vibrating microtome VT1000S (Leica, Aarau, AG, Switzerland) and mounted on polylysine-coated glass slides (Kindler, Freiburg, BW, Germany). Sections were treated in SDS for 5 min, blocked for 15 min with bovine serum albumin, and incubated with primary antibodies overnight at 4°C. Sections were washed three times with PBS/high salt (0.3 M NaCl) and, once with PBS, incubated with Alexa-labeled secondary antibodies and 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen Carlsbad, CA, USA; diluted 1:1000) to mark cell nuclei. After washing the sections twice with PBS/high salt and once with PBS, these were mounted in an aqueous mounting medium (Glycergel, Dako, Glostrup, Denmark) and were viewed on a Leica 5500B microscope (Leica, Aarau, AG, Switzerland), and pictures were processed using Adobe Photoshop.
Amino acids measurements in plasma and organs
For the quantification of amino acids, a LC-MS/MS-based method with aTRAQ® labeling reagent kit (ABSciex, Foster City, USA) was employed [44] . For analysis of tissue amino acids (brain, liver, kidney), small pieces of tissues were homogenized in liquid nitrogen. Amount of 100 mg of homogenized tissue was dissolved in 150 μL MeOH/H 2 O (50/50, v/v), vortexed, and centrifuged. Sample preparation was done according to the manufacturer's instructions using 40 μL of the supernatant of the tissue homogenates or 40 μL plasma. Tissue amino acid concentrations were standardized with protein concentrations determined via Bradford assay (Bio-Rad Laboratories GmbH, Germany).
Plasma glucose, insulin, and ammonium measurements
Blood glucose measurements were carried out using ACCU-CHEK Aviva Plus system (Roche, Basel, BS, Switzerland). The mice were anesthetized, and one drop of blood from the tail vein was collected for glucose measurements. Plasma insulin measurements were performed using the ultra-sensitive mouse insulin ELISA kit according to the manufacturer's instructions (Crystal Chem, Downers Grove, IL, USA). Similarly, plasma ammonium measurements were performed using the Sigma ammonium assay kit according to the manufacturer's instructions (Sigma-Aldrich, Saint Louis, MO, USA).
Induction of metabolic acidosis
Wildtype and heterozygous Snat3 mutant mice were placed in metabolic cages for 4 days and urine was collected under mineral oil on the last day for 24 h. One group of wildtype and mutant mice received only standard rodent chow and tap water ad libitum. The second group of mice received for the last 2 days 0.28 M NH 4 Cl in drinking water to induce metabolic acidosis as described previously [39] . Animals were sacrificed and their kidneys were harvested and immediately frozen. Urinary pH was measured using a pH microelectrode (691 pH meters, Metrohm, Herisau, AR, Switzerland). Urinary creatinine was measured according to the Jaffe method [45] . Urinary ammonium was measured by the Berthelot method [3] .
Statistical analysis and graphs
The results are expressed as mean±SEM. All data were tested for significance using the one-way ANOVA and Tukey posttest or unpaired student's t-test where appropriate. Graphs were generated using Prism GraphPad (La Jolla, CA, USA).
Results
Snat3 mutant mice die in the late weaning stage Snat3 mRNA expression was first studied in wildtype mice. Real-time PCR confirmed a significant expression of Snat3 in the brain, kidneys, eyes, skeletal muscles, and the highest expression in liver (Fig. 1a) . However, since 14-day-old mice could not provide enough material for the experiments on muscles and the eyes, further studies were performed only on the brain, kidneys, and liver. Mutant mice were obtained from screening a library of sperm generated using ENU mutagenesis [27] . Deletion of Snat3/Slc38a3 in mice was lethal; homozygous mutant mice (Snat3
) died between 18 and 20 days after birth, whereas no increased lethality was observed for heterozygous mice (Snat3
). Homozygous mutant mice were easily distinguishable by their small size (Fig. 1c) Fig. 1d-f ). Western blot analysis did not detect any Snat3 protein expression in tissue extracts of the brain, liver, and kidney from Snat3 −/− mice, demonstrating that the mutation leads to the ablation of Snat3 expression (Fig. 1g-i , and wildtype mice. In comparison to their wildtype littermates, mutant mice showed a significant decrease of blood glucose and insulin levels, suggesting that SNAT3 is involved in glucose homeostasis (Fig. 3a, b) . Therefore, we next examined the expression of enzymes involved in hepatic gluconeogenesis. Phosphoenolpyruvate carboxykinase (PEPCK) was upregulated significantly at both mRNA (Fig. 3c ) and protein levels (Fig. 3f, g ). In contrast, glutaminase 2 (GLS2) showed no changes at mRNA level (Fig. 3d) , but the GLS2 protein was massively downregulated in mutant mice (Fig. 3h, i) . Surprisingly, glutamine synthetase 1 (GLU1) was strongly upregulated at the mRNA level (Fig. 3e ) but downregulated at the protein level (Fig. 3j, k) .
The mTOR pathway is reduced in Snat3-deficient mice Glutamine and other neutral amino acids are known to play a role in intracellular amino acid sensing. Since the mutant mice displayed altered plasma glucose and insulin levels and had reduced growth, we assumed that intracellular amino acid sensing via the mTOR pathway was affected [11, [30] [31] [32] . Accordingly, leucine, phenylalanine, and tryptophane which can stimulate mTOR showed reduced levels in liver tissues of mutant mice (Fig. 4a-c) . Additionally, the insulin-like growth factor 1 (IGF1), which is an activator of the mTOR pathway, was also downregulated in Snat3-deficient mouse liver (Fig. 4d) . Moreover, the total and phosphorylated forms of mTOR were massively downregulated in mutant mice compared to wildtype littermates (Fig. 4e-h ). Whereas the nonphosphorylated form of the ribosomal protein S6 kinase (S6K) showed no difference between genotypes, the phosphorylated form of S6K was significantly less abundant in Snat3-deficient mice (Fig. 4i-l) . The ratio of phospho-protein versus total protein was significantly lower in mutant mice for S6K whereas no difference was found for mTOR (Fig. 3m, n) . This suggests that the decrease of phosphorylated mTOR parallels the decrease of total mTOR expression whereas the decrease of phospho-S6K was due to a decrease in the phosphorylation state of this protein possibly because of a reduced mTOR activity.
Mutant Snat3 mice show an altered hepatic urea cycle
The liver is responsible for detoxification of ammonia by converting it into urea through the urea cycle [25] . Because SNAT3 is highly expressed in the liver and is likely to be involved in the urea cycle, we examined the hepatic urea cycle in the mutant mice. Serum urea levels were substantially increased in mutant mice in comparison to littermates (Fig. 5a ), but no difference was observed in plasma ammonium levels between genotypes (Fig. 5b) . Hepatic carbamoyl phosphate synthetase I (Cps1) and ornithine transcarbamylase (Otc) mRNA expression showed no significant differences in mutant mice compared to wildtype animals, whereas argininosuccinate lyase (Asl) and arginase I (Arg1) levels were significantly increased in mutant mice (Fig. 5c-f The glutamate-glutamine cycle is defective in the brain of Snat3-deficient mice SNAT3 is highly expressed in brain astrocytes and is believed to play a role in the glutamate-glutamine cycle involved in neurotransmission [5, 12, 36] . The lethargy and an altered, uncoordinated gait observed in mutant mice suggested impaired neurotransmission after Snat3 deletion in brain. We thus measured the concentrations of different amino acids and neurotransmitters involved in the glutamate-glutamine cycle (Supplementary Table 4 ). Glutamine abundance was higher whereas glutamate and GABA levels were lower in the brains of mutant animals ( Fig. 6a-c) . We also assessed the expression of the glutamine and glutamate transporters implicated in the glutamate-glutamine cycle. The system A transporters Snat1 and Snat2 showed no difference at mRNA levels in mutant mice when compared to wildtype and heterozygous littermates (Fig. 6d, e ). Yet, Snat1 is expressed exclusively in neurons [14, 34, 49] and was significantly upregulated in the brain of mutant mice at the protein level (Fig. 6j,  k) . The system N transporter Snat5 was downregulated at the mRNA level (Fig. 6f) . No changes were observed at mRNA or protein levels in expression of any of the glutamate transporters Slc1a1 (Eaac1 or Eaat3) and Slc1a2 (Glt-1 or Eaat2) (Fig. 6g, h and l, m) . The mRNA expression of glutamine synthetase (Glu1), which mediates the conversion of ) animals, n=9/genotype. c-e mRNA abundance of phosphoenolpyruvate carboxykinase (Pepck) was upregulated whereas glutamine synthetases (Glu1) and (Gls2) were downregulated at mRNA level in Snat3-deficient animals. f-k Expression of the Pepck was increased whereas the abundance of glutaminase 2 (Gls2) and glutamine synthetase (Glu1) was downregulated. All blots were reprobed for β-actin to control for loading and β-actin used for calculation of relative abundance. Normalized data are presented as bar graphs showing mean±SEM. n=11-12/genotype for qPCR, n= 5-6/genotype for immunoblots. *P≤0.05, **P≤0.01, ***P≤ 0.001 glutamate to glutamine in astrocytes, showed no difference between genotypes (Fig. 6i) . Lastly, protein expression of the system L-amino acid transporter 1 (LAT1) mediating the transport of neutral amino acids and expressed in brain vessels [18] and possibly also in neurons [26] was significantly increased in mutant mice when compared to wildtype (Fig. 6n, o) .
Impaired ammoniagenic pathway in the kidney
We next investigated the involvement of SNAT3 in ammoniagenesis in the kidney. Glutamine and glutamate were both less abundant in the kidneys of Snat3-deficient animals (Fig. 7a, b, Supplementary Table 5 ). Urine spot samples were collected as it was impossible to collect 24-h urine samples from 2-week-old pups. Urinary NH 4 + and urea excretion was significantly reduced in homozygous Snat3 mutant mice in comparison to wildtype and heterozygous littermates (Fig. 7c, d ). The enzymes involved in ammoniagenesis: phosphate-dependent glutaminase (Pdg) showed elevated levels but no change in phosphoenolpyruvate carboxykinase (Pepck) in Snat3 −/− mice (Fig. 7e, f) .
The RhCG transporter is primarily expressed in the connecting tubule and the collecting duct and plays an important ), n=11-12/genotype. e-f Bar graphs showing ratios of phosphorylated proteins to total proteins. g-n Immunoblotting for hepatic total non-phosphorylated and phosphorylated mammalian target of rapamycin (mTOR) and S6 kinase (S6K). All blots were reprobed for β-tubuline or β-actin to control for loading. Bar graphs show means± SEM of the ratio of the protein of interest over loading control. Both total non-phosphorylated and phosphorylated mTOR were significantly downregulated in homozygous mutant Snat3 mice. Total S6K showed no difference in all mice, but phosphorylated S6K was massively reduced in Snat3-deficient mice. *P≤0.05, **P≤0.01 role in apical NH 4 + extrusion into the final urine [4, 6] . Mutant mice showed no changes in renal mRNA expression of Rhcg ( Supplementary Fig. 1A ). Snat2 and Snat5 are both highly expressed in the kidney and could potentially compensate for the loss of Snat3 function in mutant mice. However, no changes in mRNA expression were observed for Snat2 ( Supplementary  Fig. 1B ). In contrast, Snat5 was significantly downregulated in mutant mice compared to heterozygous and wildtype animals ( Supplementary Fig. 1C ). However, no specific antibodies were available to test protein abundance and renal localization. The system L-amino acid transporter 2 (LAT2), an antiporter for neutral amino acids expressed in the kidney [19] , is likely involved in the efflux of glutamine from proximal tubular cells [42] and was found downregulated at the protein level in mutant mice (Fig. 7g, h ).
Since homozygous mutant mice are not viable enough to perform acid-loading tests to stimulate ammoniagenesis and because heterozygous mutant mice showed reduced Snat3 protein expression, we tested if 12-week-old heterozygous mice could adapt renal ammoniagenesis. Wildtype and heterozygous mice were given NH 4 Cl for 2 days to induce a metabolic acid load. Both groups of mice consumed similar amounts of the NH 4 Cl drinking water and developed metabolic acidosis with similar falls in blood pH and blood bicarbonate (data not shown). Moreover, after 2 days of acid load, both wildtype and heterozygote mice showed a similar increase in total urinary NH 4 + excretion (Fig. 8a ) and a decrease in urinary pH (Fig. 8b) . However, renal Pdg and Pepck, but not Snat3, showed significantly higher mRNA levels in heterozygote mice after acid loading compared to wildtype mice (Fig. 8c-e) . This suggests that a higher induction of these enzymes may be required to reach the same level of ammoniagenesis as in wildtype animals.
Discussion
This is the first report on the deletion of a member of the SLC38 family of glutamine transporters in an animal. Several members of the SLC38 family have been studied extensively in heterologous and other in vitro systems [9, 23, 37, 46] , but their function in vivo is mainly unknown. Here we report a severe phenotype of mice lacking Snat3 due to an early stop codon introduced by random ENU mutagenesis. Mice deficient of Snat3 die early before weaning and display ataxia, multiple defects in amino acid homeostasis, glucose metabolism, glutamate-glutamine cycle, and renal ammoniagenesis. Together, these impairments might explain the early death of mutant mice after 20 days of life.
SNAT3 is an amino acid transporter with substrate specificity for glutamine, histidine, serine, and asparagine. Slc38a3 mutant mice had elevated plasma histidine levels whereas serine, glutamine, and asparagine levels remained unaltered. These data indicate that the alterations in the plasma amino acid profile most likely reflect secondary changes in cellular metabolism. Glutamine levels in plasma may be unaltered because the pool of glutamine is large and because SNAT3 most likely serves as uptake transporter into renal proximal tubule cells and hepatocytes using glutamine as substrate for the urea cycle and gluconeogenesis (see below). In brain, SNAT3 serves the local recycling of glutamine and disruption Snat3 deficiency affects urea cycle and metabolism. a Urea was significantly increased in the plasma of Snat3-deficient mice, n=5-13/genotype. b Plasma ammonium levels were unchanged in all genotypes, n= 9-10/genotype. c-f mRNA expression of enzymes involved in the urea cycle. Carbamoyl phosphate synthetase I (Cps1) and ornithine transcarbamoylase (Otc) and were not altered, whereas argininosuccinate lyase (Asl) and arginase 1 (Arg1) were upregulated in the liver from Snat3-deficient animals n=11-12/genotype. *P≤0.05 of this function is not expected to alter systemic glutamine levels.
Snat3-deficient mice suffered from altered energy metabolism. Homozygous mutant mice were hypoglycemic and the decrease in plasma glucose may originate from a reduced hepatic capacity for gluconeogenesis. The low insulin levels measured would be the appropriate compensation for this primary fall in glucose levels. The lack of Snat3 significantly lowered hepatic glutamine levels with glutamine as a main substrate for gluconeogenesis. The decrease in plasma and hepatic alanine content, the decrease in plasma insulin, the upregulation of the gluconeogenic enzyme Pepck, as well as Rel. abund of Lat1
WT
Snat3 -/-
the downregulation of Gls2 observed in Snat3-deficient animals point to an increased use of alanine as a glucogenic amino acid due to reduced availability of glutamine. Hence, changes in alanine concentrations are most likely to be a secondary effect of Snat3 deletion as alanine is not a substrate of SNAT3 [8, 22] . As the increased Snat5 expression observed disagrees with the decreased hepatic alanine content, Snat4 which is highly expressed in liver could explain this difference [48] . A previously unrecognized function of SNAT3 appears to be its role in histidine removal and metabolism by the liver. The liver is the main site of histidine metabolism, depending, at least in part, on the uptake via SNAT3. Snat3-deficient mice also exhibited changes in the mTOR/ S6K signaling pathway that plays a major role in sensing of intracellular amino acids and is involved in regulation of protein synthesis, energy metabolism, cellular proliferation, and body growth [30] [31] [32] . mTOR activity is particularly sensitive Fig. 6 Loss of Snat3 in the brain reduces neurotransmitter abundance and stimulates alternative transporter expression. a-c Quantification of amino acid concentrations in the brain. The brain of homozygous mutant Snat3 animals showed increased glutamine (Gln) levels but lower abundance of glutamate (Glu) and gamma-aminobutyric acid (GABA). Amino acid levels were normalized to total protein content (μmol/L/μg/ μL), n=6. d-i The brain mRNA expression of the sodium-coupled neutral amino acid transporter 1 (Snat1), 2 (Snat2), and 5 (Snat5), the excitatory amino acid transporter 3 (Slc1a1), the excitatory amino acid transporter 2 (Slc1a2), and glutamine synthetase (Glu1) was measured by RT-qPCR in all mice, and only Snat5 mRNA was significantly reduced in Snat3-deficient mice, n=10-12/genotype. j-o Immunoblotting for the sodium-coupled neutral amino acid transporter 1 (Snat1), the excitatory amino acid transporter 2 (Slc1a2), and the large neutral amino acid transporter 1 (Lat1). All membranes were reprobed for β-actin to control for loading. Normalized protein expression was calculated and is shown in bar graphs. The glutamate transporter Slc1a2 showed no difference, but Snat1 and Lat1 were upregulated in brains from Snat3-deficient mice. . Glutamine (Gln) and glutamate (Glu) levels were both reduced in the kidneys of Snat3-deficient animals, n=6/genotype. c, d Homozygous Snat3 mutant mice showed reduced urinary NH 4 + and urea excretion normalized to creatinine in the urine, n = 6-14/genotype. e, f Immunoblotting of phosphate-dependent glutaminase (Pdg) and renal phosphoenolpyruvate carboxykinase (Pepck), n=4/genotype. Pepck showed no difference but Pdg was upregulated in kidneys form Snat3-deficient mice. g, h Reduced expression of the large neutral amino acid transporter 2 (Lat2) in the kidneys of Snat3-deficient mice. The membrane was reprobed for β-actin to control for loading. Bar graph shows normalized protein expression to the availability of essential amino acids such as tryptophan, phenylalanine, arginine, and leucine as well as not only to glutamine [38] but also to glucose, insulin, and insulin-like growth factor 1 (IGF1) levels [32] . Therefore, the decrease in glutamine, phenylalanine, tryptophan, glucose, insulin, and IGF1 availability observed in the Snat3-deficient mice could lead to the substantial reduction of the levels of the activated forms of both mTOR and S6K. Reduced activation of mTOR points to a collaboration between LAT1 and SNAT3 in providing amino acids for mTOR activation. Glutamine is taken by SNAT3 and can serve as an exchange substrate for leucine and tryptophan uptake by LAT1. Thus, the role of SNAT3 in liver is similar to that of ASCT2 in cancer cells and SNAT2 in muscle cells [20, 21] . Further, such a reduced mTOR signaling might be one reason why Snat3-deficient mice suffer from growth retardation in the neonatal period [54] .
SNAT3 properties and the cellular distribution within the liver suggest its involvement ammonia detoxification from the portal blood via the urea cycle [22, 25] . SNAT3 would deliver glutamine which is converted to glutamate which together with ammonium enters the urea cycle with urea finally excreted via kidneys. In the absence of Snat3, plasma ammonium levels remained unaltered whereas plasma urea levels were increased. We hypothesize that a reduced glutamine transport into periportal hepatocytes would result in a reduced NH 4 + production from the catabolism of glutamine to glutamate with reduced levels of NH 4 + available for ureagenesis. However, the increase in arginase (Arg1) and argininosuccinate lyase (Asl) observed in Snat3-deficient mice indicates that some compensatory mechanisms are in place to maintain urea production. Alternatively, low glucose levels may trigger increased protein catabolism to maintain energy production, and the elevated urea levels and higher expression of enzymes may reflect enhanced formation of NH 4 + from protein breakdown. A third possibility would be decreased renal clearance of urea [1] ; however, creatinine levels were in the normal range suggesting that the renal function was not completely disturbed. Thus, the higher urea levels may be the result of disturbances at various levels and the early death of mutant animals complicates a detailed analysis.
In the brain, the deletion of Snat3 caused changes in the expression of several amino acid transporters as well as of amino acid and neurotransmitter levels consistent with a major role of the protein in the glutamate-glutamine cycle. Disrupted neurotransmitter synthesis could also explain the neurological disturbances seen in the Snat3-deficient mice. Glutamate released into the synapse is taken up by surrounding astrocytes via the Slc1a2 (Eaat2/Glt1) and Slc1a3 (Eaat1/Glast) glutamate transporters. Some glutamate is also taken up by Slc1a1 (Eaat3/Eaac1) transporters localized in neurons. After the conversion of glutamate to glutamine by glutamine synthetase, glutamine is released, possibly via Snat3 and/or Snat5 and taken up by neurons which may involve the Snat1 and Snat2 glutamine transporters for reconversion to glutamate by glutaminases [5, 12-15, 26, 35, 36] heterozygous mice showed a more pronounced increase in Pepck, Pdg, but not Snat3 mRNA expression, n=4-6/genotype. WT (displayed in white), WT after 2 days NH 4 Cl load (displayed in light gray), Snat3
−/− (displayed in black), after 2 days NH 4 Cl load (displayed in dark gray). *P≤0.05, **P≤0.01, ***P≤0.001 uptake of glutamine into neurons and the release of glutamine from astrocytes, respectively, could be taken as an indicator of compensatory mechanisms. Concentrations of tyrosine and tryptophane, which are precursors of important neurotransmitters involved in cognitive functions, such as serotonin and dopamine, respectively, displayed reduced levels in mutant brain. Furthermore, the decrease of brain alanine concentrations might be explained by an increased Snat1-mediated alanine uptake as an additional source for glutamate synthesis [19] . Snat3 is also expressed in the endothelium of the blood-brain barrier [43] . The elevated levels of glutamine in brain tissues may suggest that the main function of Snat3 at the blood-brain barrier is not the import of glutamine into the cerebrospinal but the efflux of glutamine in coupling to other amino acid exchangers. Altogether, our results implicate Snat3 as critical if not as the major facilitator of glutamine efflux from astrocytes in supply of glutamine for neurotransmitter synthesis. Cell-specific deletions of Snat3 and other members of the SLC38 family in brain are required to define their specific functions in neurotransmission.
In the kidney, glutamine is the primary metabolic source for the release of NH 3 , which when excreted as NH 4 + helps to save CO 2 for de novo synthesis of bicarbonate to restore systemic acid-base balance. The uptake of glutamine for ammoniagenesis has been attributed to Snat3 because Snat3 shows induction in parallel to increased ammoniagenesis [9, 37, 46] . Snat3-deficient mice showed a decrease in urinary ammonium excretion consistent with impaired ammoniagenesis. The upregulation of the phosphate-dependent glutaminase (Pdg), as well as the downregulation of Lat2 as a basolateral efflux pathway for glutamine, is likely a result of compensatory mechanisms to correct the decrease in glutamine availability. Similarly, the observed upregulation in Pepck protein expression in kidney might indicate a compensation for a decrease of α-ketoglutarate availability. On the other hand, fasting increases Pepck-mRNA-apparently not reverted by glucose or insulin but by bicarbonate [28] . This suggests that increased Pepck in kidney is a measure of acidosis by impaired ammoniagenesis rather than of increased gluconeogenesis [28] . The early lethality in homozygous mutants made it impossible to conduct further metabolic experiments on renal functions. Since heterozygotic mice had reduced expression of SNAT3, we tested whether a partial defect in Snat3 could be functionally relevant during an oral acid load. Heterozygous mice showed similar changes in urinary pH and NH 4 + excretion as wildtype animals. However, heterozygous mice obviously required a higher induction of Pdg and Pepck mRNA expression to achieve similar NH 4 + excretion rates, suggesting that the partial loss of Snat3 impacts on ammoniagenesis.
In conclusion, our results demonstrate that SNAT3 is a transporter for glutamine that is crucial for amino acid homeostasis in the brain, liver, and kidney. Moreover, signaling processes that mediate growth such as the mTOR/S6K pathway revealed changes that may also explain the retarded growth of animals lacking Slc38a3. Early lethality in mice prevented detailed analysis of organ-specific alterations, and thus future studies on the physiological importance of SNAT3 and of glutamine need tissue-and cell-type-specific deficiencies.
